Vol 9, No 6 (December 27, 2020): Chinese Clinical Oncology

Editorial on Targeted Systemic Therapies for Primary and Metastatic Brain Tumors1

Targeted systemic therapies for primary brain tumors
Lyndon Kim

Original Article

Real-world assessment of the effect of impact of tumor size on pathological complete response rates in triple negative breast cancer after neoadjuvant chemotherapy
Bruno Henrique Rala de Paula, Sanjeev Kumar, Fabiola Marques Morosini, Debora Evelyn Martins Calábria Cardoso, Carlos Augusto Moreira de Sousa, Susanne Crocamo

Letter to the Editor

Collateral damage of COVID-19 pandemic on oncology clinical trials
Sri Harsha Tella, Anuhya Kommalapati, Steve R. Alberts, Robert McWilliams, Amit Mahipal


1. The series “Targeted Systemic Therapies for Primary and Metastatic Brain Tumors” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Jon Glass served as the unpaid Guest Editor for the series.